SEARCH

SEARCH BY CITATION

References

  • Basco L & Ringwald P (1998a) Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthetase gene of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 58, 369373.
  • Basco L & Ringwald P (1998b) Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 58, 374377.
  • Basco L, De Pecoulas P, Wilson C, Le Bras J & Mazabraud A (1995) Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular Biochemical Parasitology 69, 135138.
  • Blakeley RL (1984) Folates and Pteridines, Vol. 1 (eds RLBlakeley & SJ Benkovics) Wiley, New York, pp. 191253.
  • Brooks D, Wang P, Read M, Watkin W, Sims P & Hyde J (1994) Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry 224, 397405.
  • Cortese JF & Plowe V (1998) Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Molecular Biochemical Parasitology 94, 205214.
  • Curtis J, Duraisingh MT, Trigg JK, Mbwana H, Warhurst DC & Curtis CF (1996) Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 678680.
  • Duraisingh MT, Curtis J & Warhurst DC (1998) Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Experimental Parasitology 89, 18.
  • Eberl KJ, Jelinek T, Aida AO et al. (2001) Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania. Tropical Medicine and International Health 6, 756760.
  • Foote S, Galatis D & Cowman A (1990) Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the USA 87, 30143017.
  • Gyang FN, Peterson DS & Wellems TE (1992) Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Experimental Parasitology 74, 470472.
  • Jelinek T, Rønn AM, Lemnge MM et al. (1998) Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. Tropical Medicine and International Health 8, 605609.
  • Kain KC & Lanar DE (1991) Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. Journal of Clinical Microbiology 29, 11711174.
  • Kondrachine AV & Trigg PI (1997) Global overview of malaria. Indian Journal of Medical Research 106, 3952.
  • Malaria Foundation International (2002) homepage: www.malaria.org.
  • Peterson D, Milhous W & Wellems T (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the USA 87, 30183022.
  • Plowe CP, Kuplin JG & Doumbo OK (1998) Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resistance Updates 1, 389396.
  • Reeder J, Rieckmann K, Genton B, Lorry K, Wines B & Cowman A (1996) Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. American Journal of Tropical Medicine and Hygiene 55, 209213.
  • Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y & Santi DV (1997) Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proceedings of the National Academy of Sciences of the USA 94, 11241129.
  • Triglia T & Cowman AF (1994) Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA 91, 71497153.
  • Walter RD (1991) Folate metabolism as a target for chemotherapy of malaria. In: Biochemical Protozoology (eds GHCoombs & MJ North) Taylor & Francis, London, pp. 560568.
  • Wang P, Brooks DR, Sims PFG & Hyde JE (1995) A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Molecular Biochemical Parasitology 71, 115125.
  • Wang P, Reed M, Sims P & Hyde J (1997) Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilisation. Molecular Microbiology 23, 979986.
  • Zolg JW, Chen GX & Plitt JR (1991) Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Molecular Biochemical Parasitology 39, 257265.